ʻOiai kekahi mau kūlanakauhale ma ʻAmelika Hui Pū ʻIa i kēia manawa pāpāt mea hoano e-wai, a ke aʻo hou mai ka Boston University School of Medicine hoʻolaha ua ʻike ʻo ia i ka ʻona o nā ʻala no nā kīʻaha koko.
KA E-CIGARETE PILI NO NA AE KOKO?
Hiki paha i nā e-liquid ke hoʻopōʻino i ke kino? ʻO kēia ka nīnau i nīnau ʻia e kahi hui o nā mea noiʻi mai Boston University School of Medicine iā lākou iho.
Mahalo nui ia i nā mea hoʻohui ʻono i kūleʻa ai ka e-cigarette i ka hoʻokumu ʻana iā ia iho ma ke ʻano he ʻokoʻa i nā huahana paka. ʻOiai he nui nā haʻawina i hana ʻia e pili ana i ka pilikia o ka e-cigarettes no ka māmā, he kakaikahi nā haʻawina i nānā i nā kīʻaha koko a pehea e hoʻopilikia ai nā mea ʻala i ke kino o ke kanaka. ʻO ka mea kikoʻī, ʻaʻohe haʻawina i nānā pono i ka ʻona o nā mea hoʻohui ʻono i nā kīʻaha koko.
ʻO nā mea noiʻi mai ka Faculty of Medicine Ke Kulanui ʻo Boston (BUSM) no laila ua aʻo i nā hopena pōkole o nā huahana 
kemika hoʻonoʻo i hoʻohana ʻia i loko o ka e-cigarettes ma nā pūnaewele endothelial, nā cell e laina ana i nā kīʻaha koko. Me kēia noiʻi ʻana, ʻike nā mea noiʻi i ka wā i ʻike ʻia ai nā kīʻaha koko i nā mea hoʻohui ʻono, hoʻokuʻu ʻia nā kinikona e hoʻoikaika i ke kahe o ke koko a hoʻonui ʻia ka mumū. Ua ʻike pū lākou ua hōʻike ka endothelial cell mai nā mea puhi puhi i ka ʻawaʻawa like me nā mea i mālama ʻia me nā mea ʻono.
« Hōʻike kā mākou mau hualoaʻa he mea ʻawaʻawa nā mea hoʻohui ʻono i nā kīʻaha koko a loaʻa nā hopena ʻino lōʻihi i ka ʻona o ka maʻi cardiovascular e like me ka mea i ʻike ʻia me ka puhi paka.", Wehewehe ʻO Jessica Fetterman, Ph.D., kokua kumu lapaau ma BUSM.
Ua paʻi ʻia kēia mau ʻike ma ka puke pai Arteriosclerosis, Thrombosis, and Vascular Biology. Ua kākoʻo ʻia ke aʻo ʻana e ka National Heart, Lung and Blood Institute (NHLBI), ka Center for Tobacco Products (CTP) o ka FDA.
